BioVie Inc (NASDAQ:BIVI) has a beta value of 1.06 and has seen 0.55 million shares traded in the recent trading session. The company, currently valued at $41.52M, closed the recent trade at $2.25 per share which meant it gained $0.02 on the day or 0.90% during that session. The BIVI stock price is -1371.11% off its 52-week high price of $33.10 and 53.78% above the 52-week low of $1.04. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.91 million shares traded. The 3-month trading volume is 6.20 million shares.
The consensus among analysts is that BioVie Inc (BIVI) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
BioVie Inc (NASDAQ:BIVI) trade information
Sporting 0.90% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BIVI stock price touched $2.25 or saw a rise of 7.41%. Year-to-date, BioVie Inc shares have moved 12.50%, while the 5-day performance has seen it change 7.66%. Over the past 30 days, the shares of BioVie Inc (NASDAQ:BIVI) have changed -23.73%. Short interest in the company has seen 1.92 million shares shorted with days to cover at 0.15.
BioVie Inc (BIVI) estimates and forecasts
The company’s shares have lost -45.14% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 5.73% over the past 5 years.
BIVI Dividends
BioVie Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
BioVie Inc (NASDAQ:BIVI)’s Major holders
Insiders own 13.69% of the company shares, while shares held by institutions stand at 9.99% with a share float percentage of 11.57%. Investors are also buoyed by the number of investors in a company, with BioVie Inc having a total of 55.0 institutions that hold shares in the company. The top two institutional holders are ALTIUM CAPITAL MANAGEMENT LP with over 1.98 million shares worth more than $0.79 million. As of 2024-06-30, ALTIUM CAPITAL MANAGEMENT LP held 4.4248% of shares outstanding.
The other major institutional holder is SABBY MANAGEMENT, LLC, with the holding of over 0.73 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.29 million and represent 1.6362% of shares outstanding.
